Avalyn Pharma Earnings Call Transcripts

Fiscal Year 2026

Jefferies Global Healthcare Conference 2026

The company is advancing inhaled therapies for pulmonary fibrosis, aiming to improve tolerability and efficacy over current oral treatments. Key programs are in late-stage clinical trials, with strong long-term data and a robust financial position to support further development and potential market leadership.

Read full transcript →